Celonic Inaugurates “Next Generation” Biologics Development Center (BDC) and Pilot Plant in Basel, Switzerland

Reducing the cost and risks of scaling-up biologic medicine production

20-Jun-2024 - TheCelonic Group, a Swiss Based Quality Biologics Contract Development and Manufacturing Organization (CDMO) today opened its “Next Generation” Biologics Development Center and Pilot Plant in Basel, Switzerland. This laboratory expansion will help pharmaceutical companies develop and optimize ...

TU Graz Bundles Its Strengths in Biotechnology and Artificial Intelligence

09-May-2024 - In a multidisciplinary research project, researchers from the biosciences, process engineering and computer science want to massively increase efficiency in the development of new enzymes and process optimization. This should even enable the breakdown of forever chemicals. Graz University of ...

Variolytics receives seven-figure seed funding for climate-neutral wastewater treatment plants

Proprietary measurement technology and AI-based process control to avoid greenhouse gases in wastewater treatment

13-Dec-2022 - Germany’s almost 10,000 municipal wastewater treatment plants consume around 4,400 gigawatt hours (GWh) of electricity per year, which makes them one of the largest electricity consumers. This is equivalent to the electricity needs of 900,000 four-person households. Moreover, the greenhouse gases ...

Global Bioenergies reaches 87% of yield target in Isobutene process

12-Oct-2018 - Global Bioenergies announces that a new milestone has been met in the development of its Isobutene process. The company announces a yield exceeding 87% of the final target during the complete production phase, at laboratory scale. The productivity is also progressing quickly. Yield and ...

Merck expands biotech capacities

Swiss facility in Aubonne grows

30-Jun-2017 - Merck inaugurated a new packaging building at its biotech manufacturing site of Aubonne, Switzerland. The inauguration ceremony was attended by Merck’s Chairman of the Executive Board and CEO Stefan Oschmann, as well as personalities from the local political, economic and scientific scene. “This ...

Novasep and instrAction enter a worldwide strategic alliance for non-chiral chromatography

21-Jul-2010 - Novasep and instrAction announced that they have entered a strategic alliance. The alliance will offer customers in the life science industry a combination of instrAction’s proprietary API-selective stationary phases (Instruction® Receptor Phase) and Novasep purification capabilities and high ...

Proteros establishes Board of Directors and appoints industry experts

31-Mar-2010 - Proteros GmbH announced the formation of a Board of Directors which consists of leading experts with core competences in life sciences and corporate development. The Board will oversee all commercial and scientific activities and will support Proteros in its further corporate development and ...

ProteoNic and Genencor Sign Research Agreement

16-Jun-2009 - ProteoNic and Genencor, a Danisco Division, have signed a research agreement. As part of the contract, the two biotech companies will use ProteoNic’s UNic™ Toolbox to investigate enzyme production for Genencor’s fungal expression platforms. ProteoNic will support Genencor in applying the unique ...

Bayer Strengthens Research and Development

Pharmaceutical pipeline is well filled, with 50 projects currently in phases I to III of clinical testing

16-Dec-2008 - The Bayer Group is to further expand its research and development activities despite the current financial and economic crisis. “The task now is to set the right course. Only through innovation can our company generate the growth that is essential to safeguard its sustained success,” said Werner ...

Pall Opens New Centre of Excellence in India to Serve Fast-Growing Life Sciences Market

21-May-2007 - As part of its global initiative to align with customers worldwide, Pall Corporation inaugurated its newest Life Sciences Centre of Excellence in Bangalore, India. The Centre shall drive process optimization innovations for the global life sciences market to meet the evolving opportunities and ...